Skip to main content
. Author manuscript; available in PMC: 2019 Jul 31.
Published in final edited form as: Circulation. 2018 Jul 31;138(5):513–526. doi: 10.1161/CIRCULATIONAHA.117.031635

Figure 7. BMP9 Signaling is Attenuated by Endoglin and Limits Cardiac Fibrosis in Heart Failure.

Figure 7

Left, Endoglin promotes cardiac fibrosis by facilitating TGFβ1 and inhibiting BMP9 signaling in heart failure

Middle, Loss of BMP9 activity promotes Smad3 dominant signaling and increases cardiac fibrosis

Right, Recombinant BMP9 or neutralizing endoglin activity increases BMP9 signaling, promotes Smad1 dominant signaling and decreases cardiac fibrosis in heart failure.